Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-19-005131
Filing Date
2019-07-16
Accepted
2019-07-16 20:35:07
Documents
1
Period of Report
2019-07-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 6427
  Complete submission text file 0001387131-19-005131.txt   8074
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Issuer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address LEV PHARMACEUTICALS INC 122 EAST 42ND STREET STE 206 NEW YORK NY 10022
Business Address
RICHMAN ERIC I (Reporting) CIK: 0001313876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35963 | Film No.: 19958107